Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus

Human Immunology

Volumn 74, Issue 9, 2013, Pages 1161-1169

  Izakovicova Holla, Lydie ^a   Borilova Linhartova, Petra ^a   Hrdlickova, Barbara ^a   Marek, Filip ^b   Dolina, Jiri ^b   Rihak, Vladimir ^c   Kala, Zdenek ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c T Bata's Regional Hospital   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ADULT; ALLELE; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GASTROESOPHAGEAL REFLUX; GENE CLUSTER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA OF THE ESOPHAGUS; BARRETT'S ESOPHAGUS; BE; CI; CONFIDENCE INTERVALS; DEOXYRIBONUCLEIC ACID; DNA; DU; DUODENAL ULCER; EAC; EC; EE; EROSIVE ESOPHAGITIS; ESOPHAGEAL CANCER; GAC; GASTRIC ADENOCARCINOMA; GASTRIC ULCER; GASTROESOPHAGEAL REFLUX DISEASE; GASTROINTESTINAL QUALITY OF LIFE INDEX; GERD; GIQLI; GU; HARDY-WEINBERG EQUILIBRIUM; HWE; IL-1; INTERLEUKIN-1; LD; LES; LINKAGE DISEQUILIBRIUM; LOWER ESOPHAGEAL SPHINCTER; NERD; NON-EROSIVE REFLUX DISEASE; ODDS RATIO; OR; PCR; POLYMERASE CHAIN REACTION; RE; REFLUX ESOPHAGITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RFLP; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; VARIABLE NUMBER TANDEM REPEAT; VNTR;

ADULT; ANIMALS; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CZECH REPUBLIC; FEMALE; GASTROESOPHAGEAL REFLUX; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MULTIGENE FAMILY;

EID: 84880949521     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.06.026     Document Type: Article

References (42)

1. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic/international gastroenterology surveillance study (Digest). Scand J Gastroenterol 1999, 231:20-28.
2. Enck P., Dubois D., Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the domestic/international gastroenterology surveillance study (Digest). Scand J Gastroenterol 1999, 231:48-54.
3. Lagergren J., Bergstrom R., Lindgren A., Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340:825-831.
4. Cameron A.J., Lagergren J., Henriksson C., Nyren O., Locke G.R., Pedersen N.L. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002, 122:55-59.
5. Mohammed I., Cherkas L.F., Riley S.A., Spector T.D., Trudgill N.J. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 2003, 52:1085-1089.
6. Holtmann G., Adam B., Liebregts T. Review article: the patient with gastro-esophageal reflux disease lifestyle advice and medication. Aliment Pharmacol Ther 2004, 20:24-27.
7. Terry P., Lagergren J., Wolk A., Neren O. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 2000, 38:186-191.
8. Chourasia D., Ghoshal U.C. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play?. Trop Gastroenterol 2008, 29:13-19.
9. Ghoshal U.C., Chourasia D. Genetic factors in the pathogenesis of gastroesophageal reflux disease. Indian J Gastroenterol 2011, 30:55-62.
10. Queiroz D.M., Guerra J.B., Rocha G.A., Rocha A.M., Santos A., De Oliveira A.G., et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004, 127:73-79.
11. Muramatsu A., Azuma T., Okuda T., Satomi S., Ohtani M., Lee S., et al. Association between interleukin-1-511C/T polymorphism and reflux esophagitis in Japan. J Gastroenterol 2005, 40:873-877.
12. Ando T., El-Omar E.M., Goto Y., Nobata K., Watanabe O., Maeda O., et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006, 55:158-164.
13. Chourasia D., Achyut B.R., Tripathi S., Mittal B., Mittal R.D., Ghoshal U.C. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol 2009, 104:2704-2713.
14. Cheng H.H., Chang Ch.S., Wang H.J., Wang W.C. Interleukin-1 and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients. J Gastroenterol Hepatol 2010, 25:1443-1451.
15. Gough M.D., Ackroyd R., Majeed A.W., Bird N.C. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?. Am J Gastroenterol 2005, 100:1012-1018.
16. Smyth M.J., Cretney E., Kershaw M.H., Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev 2004, 202:275-293.
17. Steinkasserer A., Spurr N.K., Cox S., Jeggo P., Sim R.B. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 1992, 13:654-657.
18. Dominici R., Cattaneo M., Malferrari G., Archi D., Mariani C., Grimaldi L.M., et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002, 54:82-86.
19. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22:396-402.
20. Hwang I.R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
21. Kim J.J., Kim N., Hwang S., Kim J.Y., Kim J.Y., Choi Y.J., et al. Relationship of interleukin-1 beta levels and gastroesophageal reflux disease in Korea. J Gastroenterol Hepatol 2013, 28:90-98.
22. Vamvakopoulos J., Green C., Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002, 32:2988-2996.
23. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995, 99:303-310.
24. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced Il-1beta production in vitro. Scand J Immunol 1998, 47:195-198.
25. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998, 28:2598-2602.
26. Tolusso B., Pietrapertosa D., Morelli A., De Santis M., Gremese E., Farina G., et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 2006, 7:683-695.
27. Carter M.J., Jones S., Camp N.J., Cox A., Mee J., Warren B., et al. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun 2004, 5:8-15.
28. Rafiq S., Stevens K., Hurst A.J., Murray A., Henley W., Weedon M.N., et al. Common genetic variation in the gene encoding interleukin-1 receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Gene Immun 2007, 8:344-351.
29. Labenz J., Malfertheiner P. Treatment of uncomplicated reflux disease. World J Gastroenterol 2005, 11:4291-4299.
30. Kroupa R., Dolina J., Suchankova J., Matyasova Z., Hep A. Esophageal pH-metry and manometry-contemporary review of these diagnostic methods. Ces Slov Gastroent Hepatol 2006, 60:149-156.
31. Kala Z., Dolina J., Marek F., Izakovicova Holla L. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus. J Hum Genet 2007, 52:527-534.
32. Miller G., Savary M., Monnier P. Norwendige Diagnostik: Endoskopie. Reflux-therapie 1981, 336-354. Springer-Verlag, Berlin. A.L. Blum, J.R. Siewert (Eds.).
33. Eypasch E., Williams J.I., Wood-Dauphinee S., Ure B.M., Schmulling C., Neugebauer E., et al. Gastrointestinal quality of life index: developement, validation and application of a new instrument. Br J Surg 1995, 82:216-222.
34. McDowell T.L., Symons J.A., Ploski R., Førre O., Duff G.W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995, 38:221-228.
35. di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992, 1:450.
36. Kornman K.S., Crane A., Wang H.Y., di Giovine F.S., Newman M.G., Pirk F.W., et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997, 24:72-77.
37. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993, 91:403-404.
38. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002, 123:92-105.
39. Ruzzo A., Graziano F., Pizzaqalli F., Santini D., Battistelli V., Panunzi S., et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 2005, 16:887-892.
40. Wallace J.L., Cucula M., Mugridge K., Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991, 261:559-564.
41. Rieder F., Cheng L., Harnett K.M., Chak A., Cooper G.S., Isenberg G., et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 2007, 132:154-165.
42. Cao W., Cheng L., Behar J., Fiocchi C., Biancani P., Harnett K.M. Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. Am J Physiol Gastrointest Liver Physiol 2004, 287:1131-1139.